Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by maryjanemikeon Oct 31, 2018 10:59pm

92 Views

Post# 28905819

Exactly NF vapes are so popular they sell out fast

I can`t wait for the earnings report and lets not forget the cbd water bottles sales plus whatever else Joshua Bartch is looking at in terms of a growth plan,Don`t give away anything if the vapes are this popular. Share price is a complete joke here guys . We should be trading in the 20-40 cent range

Bullboard Posts

Geologica Resource: Polymetallic upside at a depressed price